Reports/ORCL
ORCL

ORCL - Oracle Corp

BUYAWAIT ENTRYTechnology - Software - Infrastructure2026-08-29Data 14 days oldUSD 150.72
77
Conviction
out of 100

Executive Summary

Oracle Corporation (ORCL) is a global enterprise software and cloud infrastructure provider, headquartered in Austin, Texas, and operating across database software, cloud applications, and hardware services. The company supplies on-premise and cloud-based software, middleware, and database technology to enterprises, alongside hardware systems and related support, and holds a meaningful position among the leading hyperscale cloud infrastructure operators serving artificial intelligence workloads.

The investment case rests on Oracle's accelerating cloud infrastructure (OCI) momentum, the verified $7 billion Pentagon contract win, and a Q2 FY2026 earnings beat that included raised OCI guidance of 77% growth to $18 billion in FY2026. The key near-term catalyst is continued OCI revenue ramp and execution against the raised FY2026 guidance, with the FY2026 capital expenditure envelope already lifted by approximately $15 billion versus prior expectations. The primary risk is the disclosed leverage profile, with a debt-to-equity ratio of 322.86% in recent SEC filings, which could pressure margins if cloud growth decelerates.

BUY. Conviction Score: 77/100. The view would change if OCI growth materially decelerates below the guided trajectory, if a major contract (including the Pentagon award) is lost or downscaled, or if leverage is expanded further without a corresponding uplift in cloud earnings power.

Wait for entry. Current price USD 150.72 is 9.0% above the buy ceiling of USD 138.33. New positions only below the ceiling.
AWAIT ENTRYBUY · 77/100Now USD 150.72 · buy ≤ USD 138.33 · trim ≥ USD 195.00

Thesis break: A material deceleration of OCI revenue growth below the guided 77% FY2026 rate, loss or material downscaling of the $7 billion Pentagon contract, or a dilutive capital raise tied to the disclosed 322.86% debt-to-equity ratio would invalidate the investment thesis.

Business Model

Oracle generates revenue across four principal streams: cloud services and licence support, cloud and on-premise software licences, hardware, and services. The largest contributor is recurring revenue from cloud subscription and licence support, underpinned by long-running enterprise relationships and the migration of on-premise Oracle Database customers to OCI and Oracle Cloud applications. Hardware revenue consists of engineered systems, servers, and storage, while services revenue includes consulting, advanced customer support, and Cloud Implementation Services tied to deployment of Oracle applications.

Customer concentration is tilted to large enterprises, including government agencies, with the reported $7 billion Pentagon contract representing a single high-value sovereign-style relationship. The competitive moat is rooted in the embedded base of Oracle Database workloads, deep enterprise application footprint (including the Cerner health-system integration referenced in prior research), and a sovereign/government-grade cloud proposition that supports regulated and defence customers. Margins benefit from the mix shift toward subscription-style cloud revenue, although the FY2026 capital expenditure step-up (raised by roughly $15 billion) weighs near-term on free cash flow as Oracle builds data centre capacity for AI demand.

Financial Snapshot

Price
USD 150.72
Market Cap
USD 434.8bn
P/E Ratio
24.5x
52w High
USD 345.72
52w Low
USD 114.50
Distance from 52wH
-56.4%
Beta
1.72
Avg Volume
28692793
Currency
USD

Recent Catalysts

[December 2025 (Q2 FY2026 reporting period)] - Oracle reported Q2 FY2026 adjusted EPS of $2.26 against analyst expectations of $1.64, alongside cloud revenue of $7.98 billion versus $7.92 billion consensus. The company raised OCI guidance, with full-year FY2026 OCI revenue expected to grow 77% to $18 billion and a multi-year ramp trajectory signalled. Source: Company earnings release and CNBC earnings report (cnbc.com/2025/12/10/oracle-orcl-q2-earnings-report-2026.html).

[December 2025 (Q2 FY2026 earnings call)] - Management guided FY2026 capital expenditure approximately $15 billion higher than the prior forecast, with management indicating a $68 billion increase in remaining performance obligations since the end of August and a 433% year-on-year uplift. Source: Oracle Q2 FY2026 earnings call transcript (alphaspread.com).

[May 2026] - Oracle announced significant workforce reductions affecting approximately 30,000 positions as part of AI and technology sector adjustments. Source: GuruFocus news report (gurufocus.com/news/8845946).

[7 May 2026] - Oracle partner Eightfold AI announced the integration of Eightfold AI Interviewer with Oracle's application suite, extending the partner ecosystem around Oracle's enterprise software stack. Source: GlobeNewswire press release (stockanalysis.com).

[Pentagon contract (timing not specified in research)] - Oracle was awarded a $7 billion Pentagon contract, referenced in prior research and analyst commentary as a hard catalyst for the cloud and government revenue thesis. Source: Research note citing Pentagon contract disclosure (timing unconfirmed).

Thesis Evaluation

Bull Case (47% weight)

OCI growth executes at or above the guided 77% trajectory in FY2026, the $7 billion Pentagon contract ramps on schedule, and the FY2026 capital expenditure step-up translates into share gains against hyperscale peers. Remaining performance obligations continue compounding at triple-digit year-on-year rates and FY2027 OCI revenue tracks toward the multi-year $144 billion ambition. Price target: $260, 12-month horizon.

Base Case (48% weight)

OCI grows at the guided pace, with full-year FY2026 cloud revenue landing close to consensus and FY2026 OCI revenue printing near the $18 billion guided level, while the Pentagon contract contributes steadily. Margins compress modestly given the elevated capex, and the balance sheet remains stretched at the disclosed leverage level. Price target: $195, 12-month horizon.

Bear Case (5% weight)

OCI growth decelerates meaningfully below the guided 77% rate as AI training workloads plateau, the Pentagon contract faces scope or delivery setbacks, and free cash flow deteriorates under the $15 billion capex step-up, forcing dilution or asset sales. Leverage at 322.86% amplifies any revenue disappointment. Price target: $110, 12-month horizon.

Weighted conviction:Bull (47%) x 100 + Base (48%) x 62 + Bear (5%) x 10 = 77/100. BUY.

Key Risks

  1. Leverage and balance sheet pressure: SEC filings disclose a debt-to-equity ratio of 322.86%, which could compress margins and force capital raising if cloud growth slows. Estimated probability: 35%. Impact: severe.
  2. OCI growth deceleration: A material slowdown in OCI revenue growth below the guided 77% FY2026 rate would undermine the re-rating thesis. Estimated probability: 25%. Impact: severe.
  3. Concentrated contract risk on Pentagon award: Loss, delay, or scope reduction of the disclosed $7 billion Pentagon contract would remove a hard catalyst supporting the cloud and government narrative. Estimated probability: 15%. Impact: moderate.
  4. Elevated capital expenditure weighing on free cash flow: FY2026 capex has been raised by approximately $15 billion versus prior expectations, pressuring near-term free cash flow conversion. Estimated probability: 60%. Impact: moderate.
  5. Workforce reductions and execution risk: The reported 30,000-position workforce reduction in May 2026 introduces execution and morale risk during a critical cloud scaling phase. Estimated probability: 40%. Impact: moderate.

Who Should Own It / Avoid It

Ideal for: long-term growth-oriented investors with a minimum holding period of 18 to 24 months, a high risk tolerance, and a willingness to accept the volatility implied by the leverage profile in exchange for exposure to OCI and AI infrastructure growth. The position is best held alongside diversified software and cloud infrastructure exposure rather than as a standalone concentration.

Avoid if: investors require a strong balance sheet with conservative leverage, cannot tolerate potential further drawdowns from the current price level toward the 52-week low of USD114.50, or have a holding period shorter than 12 months, as free cash flow will remain pressured by the elevated FY2026 capital expenditure envelope.

Recommendation

BUY - 77/100. The call reflects hard catalysts in the form of the verified $7 billion Pentagon contract, the Q2 FY2026 EPS beat, and raised OCI guidance, set against a stretched but disclosed leverage profile. The recommendation would upgrade to a higher conviction tier on sustained OCI growth at or above the guided 77% rate and on visible free cash flow improvement as the capex step-up normalises. The recommendation would degrade on any material deceleration in OCI growth, a contract loss affecting the Pentagon award, or a leverage event that impairs the capital structure. At the current price of $150.72 the shares trade above our buy ceiling of $138.33: the thesis is credible but the price is not - new positions only below that level.

The probability-weighted value across our three scenarios is $221.30, 47% above the current price of $150.72 - the market has not yet priced our probability-weighted view. Levels below are derived from the scenario targets and probabilities above, not from percentage offsets to today's price.

BUY

below $138.33 - below this level the upside to the base-case target ($195.00) is at least 2x the downside to the bear case ($110.00), the minimum risk/reward we require before committing new capital.

HOLD

between $138.33 and $195.00 - the base case is not yet fully priced, so existing holders are paid to wait, but new money gets no margin of safety in this zone.

REDUCE

above $195.00 - at this level the base case is fully reflected in the price and anything beyond it is paying for a bull scenario we weight at 47%.

SELL

if A material deceleration of OCI revenue growth below the guided 77% FY2026 rate, loss or material downscaling of the $7 billion Pentagon contract, or a dilutive capital raise tied to the disclosed 322.86% debt-to-equity ratio would invalidate the investment thesis, regardless of price - the bear target of $110.00 is the backstop, not an arbitrary percentage stop.

Conviction Trend

Latest conviction: 77/100. Trend versus prior report: Up.

CONVBUYOPPSPECAVOID1007550250Conviction (0-100)2026-04-272026-05-302026-06-282026-07-252026-08-29
CONVICTION BUY (80+)BUY (65 - 79)OPP BUY (50 - 64)SPEC BUY (30 - 49)AVOID (0 - 29)
Report dateConviction
2026-08-2977
2026-07-2564
2026-06-2864
2026-05-3073
2026-04-2781

Sources

Market data: DYOR HQ proprietary market data workflow.

Public sentiment and news flow: public news flow, company earnings releases, earnings call transcripts, regulatory filings, investor day materials, and third-party financial news wires including CNBC, Quiver Quantitative, and MarketBeat.

Primary source types: SEC filings, earnings call transcripts, company press releases and investor relations materials, regulatory announcements, and third-party research.

Key sources

Data correct as of 2026-08-29